Why did Charmacy Pharmaceutical's stock drop?

Charmacy's stock dropped due to weak earnings performance, sector competition, and unfavorable technical indicators suggesting overselling conditions.

What is the current market cap of Charmacy Pharmaceutical?

The current market cap is HK$554.04 million following the recent price drop to HK$5.13 per share on the HKSE market closure today. This denotes a significant decline in investor valuation.

How does Meyka AI rate Charmacy Pharmaceutical?

Meyka AI rates Charmacy Pharmaceutical B- with a Neutral recommendation, factoring in S&P 500 and sector performance, key metrics, and forecast data analysis.

What are the projections for Charmacy Pharmaceutical's stock?

Meyka AI's forecast suggests a monthly target of HK$6.74, indicating potential upside despite the current downtrend. However, long-term projections remain conservative.

What impact does the healthcare sector have on Charmacy's performance?

Operating in the competitive healthcare sector, the company's performance is influenced by broader sector trends, regulatory developments, and consumer demand dynamics.

HK Stocks

Charmacy Pharmaceutical Co., Ltd. Drops -17.39%: Earnings Struggle

ByHuzaifa Zahoor December 31, 2025December 31, 2025

Charmacy Pharmaceutical Co., Ltd. (2289.HK) experienced a significant drop of 17.39% today, closing at HK$5.13. This decline signals investor concerns regarding its current financial performance and market position within the Hong Kong healthcare sector. Let’s delve into the reasons behind this sharp decline.